Conway Capital Management’s Amgen AMGN Stock Holding History

Conway Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-926	Closed	-$326K	–	40
2026 Q1	$326K	Hold	926	–	–	0.15%	33
2025 Q4	$303K	Hold	926	–	–	0.13%	37
2025 Q3	$261K	Hold	926	–	–	0.11%	44
2025 Q2	$259K	Hold	926	–	–	0.12%	43
2025 Q1	$288K	Hold	926	–	–	0.14%	35
2024 Q4	$241K	Sell	926 -25	-3%	-$7.42K	0.11%	43
2024 Q3	$306K	Hold	951	–	–	0.15%	38
2024 Q2	$297K	Hold	951	–	–	0.15%	37
2024 Q1	$270K	Hold	951	–	–	0.15%	38
2023 Q4	$274K	Hold	951	–	–	0.18%	38
2023 Q3	$256K	Hold	951	–	–	0.19%	34
2023 Q2	$211K	Hold	951	–	–	0.15%	45
2023 Q1	$230K	Hold	951	–	–	0.19%	44
2022 Q4	$250K	Hold	951	–	–	0.25%	38
2022 Q3	$214K	Hold	951	–	–	0.19%	46
2022 Q2	$231K	Hold	951	–	–	0.21%	42
2022 Q1	$230K	Sell	951 -75	-7%	-$17.2K	0.15%	54
2021 Q4	$231K	Buy	+1,026	New	+$217K	0.14%	56
2021 Q3	–	Sell	-926	Closed	-$226K	–	70
2021 Q2	$226K	Hold	926	–	–	0.15%	65
2021 Q1	$230K	Hold	926	–	–	0.17%	65
2020 Q4	$213K	Buy	+926	New	+$213K	0.16%	66

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Conway Capital Management's AMGN Position: Q2 2026 in Review

Conway Capital Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 926 shares — an estimated $326K sold.

Conway Capital Management first reported a position in AMGN in Q4 2020 and held it in 21 quarters. The position peaked at $326K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Conway Capital Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
Conway Capital Management sold 926 Amgen shares in Q2 2026, an estimated $326K.
Conway Capital Management first reported a position in Amgen in Q4 2020 and held it in 21 quarters.
Conway Capital Management's Amgen position peaked at $326K in Q1 2026.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Conway Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.